203 related articles for article (PubMed ID: 29523222)
1. Upregulation of lncRNA CASC2 Suppresses Cell Proliferation and Metastasis of Breast Cancer via Inactivation of the TGF-β Signaling Pathway.
Zhang Y; Zhu M; Sun Y; Li W; Wang Y; Yu W
Oncol Res; 2019 Feb; 27(3):379-387. PubMed ID: 29523222
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway.
Pei Z; Du X; Song Y; Fan L; Li F; Gao Y; Wu R; Chen Y; Li W; Zhou H; Yang Y; Zeng J
Oncotarget; 2017 Mar; 8(11):18145-18153. PubMed ID: 28199978
[TBL] [Abstract][Full Text] [Related]
3. Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long Non-Coding RNA (lncRNA) Cancer Susceptibility Candidate 2 (CASC2)/AU-Binding Factor 1 (AUF1)/B-Cell CLL/Lymphoma 2 (Bcl-2) Axis.
Dai W; Mu L; Cui Y; Li Y; Chen P; Xie H; Wang X
Med Sci Monit; 2019 Jan; 25():730-738. PubMed ID: 30681073
[TBL] [Abstract][Full Text] [Related]
4. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
[TBL] [Abstract][Full Text] [Related]
5. Silencing of lncRNA EZR-AS1 inhibits proliferation, invasion, and migration of colorectal cancer cells through blocking transforming growth factor β signaling.
Liu Z; Wang N; Wang F; Zhang S; Ding J
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693738
[TBL] [Abstract][Full Text] [Related]
6. lncRNA CASC2 inhibits lipopolysaccharide‑induced acute lung injury via miR‑27b/TAB2 axis.
Li X; Mo J; Li J; Chen Y
Mol Med Rep; 2020 Dec; 22(6):5181-5190. PubMed ID: 33174006
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of lncRNA CASC2 facilitates osteosarcoma growth and invasion through miR-181a.
Ba Z; Gu L; Hao S; Wang X; Cheng Z; Nie G
Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29194827
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
[TBL] [Abstract][Full Text] [Related]
9. lncRNA CASC2/miR‑18a‑5p axis regulates the malignant potential of nasopharyngeal carcinoma by targeting RBBP8.
Miao WJ; Yuan DJ; Zhang GZ; Liu Q; Ma HM; Jin QQ
Oncol Rep; 2019 Mar; 41(3):1797-1806. PubMed ID: 30569153
[TBL] [Abstract][Full Text] [Related]
10. Long non‑coding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR‑24/MUC6 axis.
Xu DF; Wang LS; Zhou JH
Int J Oncol; 2020 Feb; 56(2):494-507. PubMed ID: 31894271
[TBL] [Abstract][Full Text] [Related]
11. Long non‑coding RNA CASC2 inhibits progression and predicts favorable prognosis in epithelial ovarian cancer.
Xue Z; Zhu X; Teng Y
Mol Med Rep; 2018 Dec; 18(6):5173-5181. PubMed ID: 30320385
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CASC2 inhibits breast cancer cell growth and metastasis through the regulation of the miR-96-5p/SYVN1 pathway.
Gao Z; Wang H; Li H; Li M; Wang J; Zhang W; Liang X; Su D; Tang J
Int J Oncol; 2018 Nov; 53(5):2081-2090. PubMed ID: 30106139
[TBL] [Abstract][Full Text] [Related]
13. The long noncoding RNA cancer susceptibility candidate 2 inhibits tumor progression in osteosarcoma.
Lu L; Dai Z; Luo Q; Lv G
Mol Med Rep; 2018 Jan; 17(1):1947-1953. PubMed ID: 29257211
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-β signaling pathway.
Wu ZJ; Li Y; Wu YZ; Wang Y; Nian WQ; Wang LL; Li LC; Luo HL; Wang DL
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):706-714. PubMed ID: 28272713
[TBL] [Abstract][Full Text] [Related]
15. Upregulated lncRNA CASC2 May Inhibit Malignant Melanoma Development Through Regulating miR-18a-5p/RUNX1.
Zhang Y; Qian W; Feng F; Cao Q; Li Y; Hou Y; Zhang L; Fan J
Oncol Res; 2019 Feb; 27(3):371-377. PubMed ID: 29422114
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA CASC2 inhibits tumorigenesis via the miR-181a/PLXNC1 axis in melanoma.
Wang Z; Wang X; Zhou H; Dan X; Jiang L; Wu Y
Acta Biochim Biophys Sin (Shanghai); 2018 Mar; 50(3):263-272. PubMed ID: 29514220
[TBL] [Abstract][Full Text] [Related]
17. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
Sun J; Liu L; Zou H; Yu W
Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
[TBL] [Abstract][Full Text] [Related]
18. E2F6-mediated lncRNA CASC2 down-regulation predicts poor prognosis and promotes progression in gastric carcinoma.
Li Y; Jiang L; Lv S; Xu H; Fan Z; He Y; Wen H
Life Sci; 2019 Sep; 232():116649. PubMed ID: 31301415
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
20. lncRNA CASC2 suppresses the growth of hemangioma cells by regulating miR-18a-5p/FBXL3 axis.
Dai YX; Qiu MK; Wang SQ; Pan C; Wang Y; Ou JM
J Biol Regul Homeost Agents; 2020; 34(1):49-56. PubMed ID: 32138500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]